Aardark Therapeutics
PublicLast Round
Series C
May 9, 2024
Total Funding Raised
$129M
Company Overview
Aardvark Therapeutics is a biopharmaceutical company specializing in small molecule therapeutics aimed at treating obesity and rare genetic metabolic diseases.
Sector
Biotech
AI Layer
Non-AI
Keywords
bitter taste receptor (TAS2R) agonistoral gut-restricted small-molecule therapeutichyperphagia treatment for Prader-Willi Syndromesatiety hormone stimulation via gut-brain axissmall-molecule therapeutics for metabolic diseaseorphan disease drug developmenthypothalamic obesity treatmentfixed-dose combination drug for obesityGLP-1 and cholecystokinin (CCK) stimulationclinical-stage biopharmaceutical company
Aardark Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Aardark Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 9, 2024 | ||||
| Series B | Aug 5, 2021 | ||||
| Series A | Nov 29, 2019 |
Aardark Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Series B, Series A |
| SymBiosis Capital Management | Series C |
| Foundation for Prader-Willi Research | Series C, Series B |
| Premier Partners | Series B, Series A |
| LG Technology Ventures | Series C |
| Cormorant Capital | Series C |
| Cantor Ventures | Series C |
Aardark Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersSan Diego, California
Employee Range37
Year Founded2017
Last FundingMay 9, 2024